Literature DB >> 31847892

Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis.

Hamzah Abu-Sbeih1, Lauren Nicholas Herrera2, Tenglong Tang1,3, Mehmet Altan4, Anne-Marie Chaftari5, Pablo C Okhuysen5, Robert R Jenq6, Yinghong Wang7.   

Abstract

Following publication of the original article [1], the authors have reported that an author's name has been incorrectly spelled: the correct given name is Anne-Marie (instead of Anne-Maria P) and family name is Chaftari.

Entities:  

Year:  2019        PMID: 31847892      PMCID: PMC6918684          DOI: 10.1186/s40425-019-0832-5

Source DB:  PubMed          Journal:  J Immunother Cancer        ISSN: 2051-1426            Impact factor:   13.751


Correction to: J ImmunoTher Cancer https://doi.org/10.1186/s40425-019-0714-x Following publication of the original article [1], the authors have reported that an author’s name has been incorrectly spelled: the correct given name is Anne-Marie (instead of Anne-Maria P) and family name is Chaftari.
  1 in total

1.  Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis.

Authors:  Hamzah Abu-Sbeih; Lauren Nicholas Herrera; Tenglong Tang; Mehmet Altan; Anne-Maria P Chaftari; Pablo C Okhuysen; Robert R Jenq; Yinghong Wang
Journal:  J Immunother Cancer       Date:  2019-09-05       Impact factor: 13.751

  1 in total
  2 in total

Review 1.  Abdominal CT manifestations of adverse events to immunotherapy: a primer for radiologists.

Authors:  Ali Pourvaziri; Anushri Parakh; Pierpaolo Biondetti; Dushyant Sahani; Avinash Kambadakone
Journal:  Abdom Radiol (NY)       Date:  2020-09

Review 2.  Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.

Authors:  Harm Westdorp; Mark W D Sweep; Mark A J Gorris; Frank Hoentjen; Marye J Boers-Sonderen; Rachel S van der Post; Michel M van den Heuvel; Berber Piet; Annemarie Boleij; Haiko J Bloemendal; I Jolanda M de Vries
Journal:  Front Immunol       Date:  2021-10-29       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.